Metropolitan Life Insurance Company (MetLife)’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,365
Closed -$5.65K 420
2024
Q1
$5.65K Sell
2,365
-414
-15% -$989 ﹤0.01% 2241
2023
Q4
$9.25K Sell
2,779
-3,085
-53% -$10.3K ﹤0.01% 2203
2023
Q3
$21.9K Buy
5,864
+1,811
+45% +$6.77K ﹤0.01% 1850
2023
Q2
$17.3K Buy
+4,053
New +$17.3K ﹤0.01% 2008
2023
Q1
Sell
-4,249
Closed -$33.7K 2336
2022
Q4
$33.7K Hold
4,249
﹤0.01% 1721
2022
Q3
$40.8K Hold
4,249
﹤0.01% 1596
2022
Q2
$30.8K Hold
4,249
﹤0.01% 1802
2022
Q1
$54.9K Sell
4,249
-13,564
-76% -$175K ﹤0.01% 1543
2021
Q4
$284K Hold
17,813
﹤0.01% 1770
2021
Q3
$286K Buy
+17,813
New +$286K ﹤0.01% 1814
2021
Q2
Sell
-15,893
Closed -$232K 2737
2021
Q1
$232K Sell
15,893
-1,896
-11% -$27.7K ﹤0.01% 1917
2020
Q4
$309K Hold
17,789
﹤0.01% 1664
2020
Q3
$326K Sell
17,789
-2,505
-12% -$45.9K 0.01% 1491
2020
Q2
$362K Hold
20,294
0.01% 1436
2020
Q1
$329K Buy
20,294
+343
+2% +$5.56K 0.01% 1306
2019
Q4
$359K Sell
19,951
-794
-4% -$14.3K 0.01% 1532
2019
Q3
$420K Buy
20,745
+3,674
+22% +$74.4K 0.01% 1403
2019
Q2
$377K Hold
17,071
0.01% 1485
2019
Q1
$233K Hold
17,071
﹤0.01% 1798
2018
Q4
$154K Buy
17,071
+1,200
+8% +$10.9K ﹤0.01% 1982
2018
Q3
$262K Buy
+15,871
New +$262K ﹤0.01% 1826
2015
Q4
Sell
-16,813
Closed -$337K 2589
2015
Q3
$337K Buy
+16,813
New +$337K ﹤0.01% 1904